Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
DexCom, Inc. - Common Stock
(NQ:
DXCM
)
82.42
+7.88 (+10.57%)
Streaming Delayed Price
Updated: 11:36 AM EDT, Jul 31, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about DexCom, Inc. - Common Stock
< Previous
1
2
...
25
26
27
28
29
30
31
32
33
...
50
51
Next >
7 Nasdaq Stocks to Sell in April Before They Crash & Burn
↗
April 03, 2024
The momentum in growth companies is likely to run out. Move on from these Nasdaq stocks to sell in April before it's too late.
Via
InvestorPlace
Dexcom Publishes Annual Sustainability Report
April 03, 2024
From
DexCom, Inc.
Via
Business Wire
Dexcom Schedules First Quarter 2024 Earnings Release and Conference Call for April 25, 2024 at 4:30 p.m. Eastern Time
April 02, 2024
From
DexCom, Inc.
Via
Business Wire
DexCom Inc Chart Analysis
↗
March 26, 2024
Technical analysis of the stock chart for DXCM.
Via
Talk Markets
Here's How Much $1000 Invested In DexCom 15 Years Ago Would Be Worth Today
↗
March 25, 2024
Via
Benzinga
NASDAQ:DXCM—Positioned as a High-Growth Stock, Ready for a Potential Breakout.
↗
March 21, 2024
DEXCOM INC (NASDAQ:DXCM) qualifies as a high growth stock and is consolidating.
Via
Chartmill
DexCom's Options: A Look at What the Big Money is Thinking
↗
March 20, 2024
Via
Benzinga
DexCom Stock Gains from GLP-1 Diabetic Users
April 02, 2024
DexCom Inc. (NASDAQ: DXCM) is a leading medical device company in the medical sector that specializes in continuous glucose monitoring (CGM) systems. People
Via
MarketBeat
3 Overvalued S&P 500 Stocks for Your ‘Do NOT Buy’ List
↗
April 01, 2024
The S&P 500’s current P/E ratio is 30% higher than a year ago, making it easier to find overvalued S&P 500 stocks to buy.
Via
InvestorPlace
Topics
Stocks
Micron, Dropbox And 2 Other Stocks Insiders Are Selling
↗
April 01, 2024
The Nasdaq 100 closed lower by around 0.1% on Thursday. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
Market Cap Game Show: Andy Cross vs. Bill Mann
↗
March 30, 2024
Join the "Rule Breaker Investing" fun.
Via
The Motley Fool
Here's How Much You Would Have Made Owning DexCom Stock In The Last 15 Years
↗
March 14, 2024
Via
Benzinga
Analyst Expectations For DexCom's Future
↗
March 12, 2024
Via
Benzinga
Dexcom Stock Shows Market Leadership, Gets Rating Upgrade. Prognosis Good.
↗
March 26, 2024
Among its other key ratings Dexcom has a near-best 98 Earnings Per Share Rating out of 99, reflecting strong profit growth this past year.
Via
Investor's Business Daily
Two Hot AI Stocks Lead S&P 500 Monday
↗
March 25, 2024
Super Micro and Micron , two big winners in 2024, led the way Monday.
Via
Investor's Business Daily
Topics
Artificial Intelligence
Stocks
More Than 86% of Analysts Who Cover These 3 Stocks Rate Them a ‘Buy’
↗
March 25, 2024
Investors should take notice of these stocks with high analyst ratings. It's time to load up your portfolio.
Via
InvestorPlace
S&P 500 Giants Lead Five Stocks Near Buy Points With Fed's Powell A Tailwind
↗
March 23, 2024
DexCom, Blackstone and Royal Caribbean head this list of five stocks.
Via
Investor's Business Daily
Topics
Economy
Stocks
Edwards Lifesciences Stock Earns Relative Strength Rating Upgrade; Hits Key Benchmark
↗
March 19, 2024
The Relative Strength (RS) Rating for Edwards Lifesciences stock jumped into a new percentile Tuesday, with a rise from 78 to 81.
Via
Investor's Business Daily
DexCom Stock Trying To Close In On Key Technical Benchmark
↗
March 18, 2024
In a welcome move, medical device DexCom stock saw its Relative Strength Rating improve from 68 to 73 on Monday.
Via
Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
↗
March 18, 2024
Via
Benzinga
DexCom Is 'Expanding Rapidly' With Multi-Year Runway Ahead, Bullish Analyst Says
↗
March 12, 2024
DexCom Inc’s (NASDAQ: DXCM) Stelo Glucose Biosensor System has been approved by the Food and Drug Administration (FDA) as the first over-the-counter (OTC)
Via
Benzinga
Tandem Diabetes Care Stock Belongs On Your Watchlist As RS Rating Jump Higher
↗
March 11, 2024
On Monday, Tandem Diabetes Care stock received an upgrade to its Relative Strength (RS) Rating, from 68 to 78.
Via
Investor's Business Daily
ServiceNow Setting Up As Three Stocks Flash Buy Signals
↗
March 09, 2024
All four stocks to watch boast solid earnings growth.
Via
Investor's Business Daily
2 Medical Device Stocks to Buy Hand Over Fist in March
↗
March 08, 2024
Don't let their modest gains over the past year mislead you; these stocks can make for great long-term investments.
Via
The Motley Fool
Palantir Technologies, SL Green Realty And A Healthcare Stock On CNBC's 'Final Trades'
↗
March 07, 2024
On CNBC’s "Halftime Report Final Trades," Jenny Harrington of Gilman Hill Asset Management named SL Green Realty Corp.
Via
Benzinga
FDA Approval For DexCom's Stelo Opens Continuous Glucose Monitoring To Masses, Analyst Expects Competitive Pricing Against Abbott's
↗
March 06, 2024
FDA greenlights DexCom's Stelo, the first OTC continuous glucose monitor for non-insulin-dependent diabetics. Competitive pricing, potential HSA benefits, and market expansion make it a significant...
Via
Benzinga
Stocks Surge, Gold Hits New All-Time High, Bitcoin Reclaims $67,000 As Powell Reassures Wall Street: What's Driving Markets Wednesday?
↗
March 06, 2024
Markets rallied across the board on Wednesday, erasing the uptick in volatility seen in the previous session, following reassurances from Fed Chair Jerome Powell regarding the Fed’s willingness to ease...
Via
Benzinga
Topics
Economy
Why Dexcom — And The Obesity Market — Could Benefit From This New FDA Win
↗
March 06, 2024
The FDA granted Dexcom's Stelo a broad clearance, meaning people without diabetes can use it.
Via
Investor's Business Daily
FDA Approves Dexcom's Stelo As First Glucose Monitoring Device Without Prescription
↗
March 06, 2024
FDA-approved Dexcom Stelo: Over-the-counter glucose monitoring for non-insulin users. Stelo, the first OTC CGM, available online without prescription from summer 2024. Continuous glucose tracking with...
Via
Benzinga
Campbell Soup, Box And 3 Stocks To Watch Heading Into Wednesday
↗
March 06, 2024
With U.S. stock futures trading mostly higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
< Previous
1
2
...
25
26
27
28
29
30
31
32
33
...
50
51
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
